REPLY: Mineralocorticoid Receptor Antagonism in Acute Myocardial Infarction Who Benefits?

被引：0
作者：
Beygui, Farzin [1 ]
Montalescot, Gilles [1 ]
机构：
[1] Pitie Salpetriere Univ Hosp, Inst Cardiol, 47 Blvd Hop, F-75013 Paris, France
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 20期
关键词：
EPLERENONE; BLOCKADE;
D O I：
10.1016/j.jacc.2016.07.783
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2241 / 2242
页数：3
相关论文
共 50 条
  • [41] The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism
    Rena J Eudy
    Vaishali Sahasrabudhe
    Kevin Sweeney
    Meera Tugnait
    Amanda King-Ahmad
    Kristen Near
    Paula Loria
    Mary Ellen Banker
    David W Piotrowski
    Carine M Boustany-Kari
    Journal of Translational Medicine, 9
  • [42] Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
    Kovarik, Johannes J.
    Kaltenecker, Christopher C.
    Domenig, Oliver
    Antlanger, Marlies
    Poglitsch, Marko
    Kopecky, Chantal
    Saemann, Marcus D.
    DIABETES THERAPY, 2021, 12 (09) : 2485 - 2498
  • [43] Determinants of the beneficial effect of mineralocorticoid receptor antagonism on exercise capacity in heart failure with reduced ejection fraction
    Dankowski, Rafal
    Kotwice, Tomasz
    Szyszka, Andrzej
    Przewlocka-Kosmala, Monika
    Sacharczuk, Wioletta
    Karolko, Bozena
    Kobusiak-Prokopowicz, Malgorzata
    Mysiak, Andrzej
    Kosmala, Wojciech
    KARDIOLOGIA POLSKA, 2018, 76 (09) : 1327 - 1335
  • [44] The Effect of Mineralocorticoid and Glucocorticoid Receptor Antagonism on Autobiographical Memory Recall and Amygdala Response to Implicit Emotional Stimuli
    Young, Kymberly D.
    Preskorn, Sheldon H.
    Victor, Teresa
    Misaki, Masaya
    Bodurka, Jerzy
    Drevets, Wayne C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (09) : 1 - 11
  • [45] The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism
    Eudy, Rena J.
    Sahasrabudhe, Vaishali
    Sweeney, Kevin
    Tugnait, Meera
    King-Ahmad, Amanda
    Near, Kristen
    Loria, Paula
    Banker, Mary Ellen
    Piotrowski, David W.
    Boustany-Kari, Carine M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [46] Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats
    Minas, Jacqueline N.
    Thorwald, Max A.
    Conte, Debra
    Vazquez-Medina, Jose-Pablo
    Nishiyama, Akira
    Ortiz, Rudy M.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (11): : 1178 - 1188
  • [47] Effects of mineralocorticoid receptor antagonist eplerenone on cardiac sympathetic nerve activity and left ventricular remodeling after reperfusion therapy in patients with first ST-segment elevation myocardial infarction
    Toda, Kazuyoshi
    Kasama, Shu
    Toyama, Takuji
    Kasahara, Masato
    Kurabayashi, Masahiko
    JOURNAL OF NUCLEAR CARDIOLOGY, 2022, 29 (05) : 2325 - 2335
  • [48] Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials
    Susan Stienen
    Patrick Rossignol
    António Barros
    Nicolas Girerd
    Bertram Pitt
    Faiez Zannad
    João Pedro Ferreira
    Clinical Research in Cardiology, 2020, 109 : 194 - 204
  • [49] Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials
    Stienen, Susan
    Rossignol, Patrick
    Barros, Antonio
    Girerd, Nicolas
    Pitt, Bertram
    Zannad, Faiez
    Ferreira, Joao Pedro
    CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (02) : 194 - 204
  • [50] Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI
    Pitt, Bertram
    Ferreira, Joao Pedro
    Zannad, Faiez
    EUROPEAN HEART JOURNAL, 2022, 43 (14) : 1428 - 1431
12345